Core Insights - The company, MicroPort Scientific Corporation, has reported that its core products in endoscopy, orthopedics, and vascular intervention have accumulated over 170 orders as of the announcement date [1] - The TuMai endoscopic surgical robot has surpassed 100 commercial orders globally, with nearly 80 units installed, making it the leading domestic brand in this sector [1] - The commercialization process for TuMai is accelerating, with over 15,000 clinical surgeries performed worldwide [1] Product and Market Expansion - TuMai is the first domestic endoscopic surgical robot to enter overseas markets, with over 60 international orders covering nearly 40 countries and regions across Asia, Europe, Africa, Oceania, and South America [1] - The product has been deployed in mainstream hospital systems in several countries, including Italy, Belgium, India, Brazil, Argentina, and the UAE, facilitating large-scale clinical surgeries [1] - A significant milestone was achieved with TuMai's deployment in a top-tier global medical institution, successfully executing a comprehensive intelligent surgical solution [1]